stars 1 stars 2 stars 3

In February, 2023 Imara merged with Enliven therapeutics (ELVN), with the resulting firm retaining Enliven’s name and development pipeline. Enliven is a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors to help patients with cancer live not only longer, but better.

View Top Employees from Imara Inc.
Website https://www.enliventherapeutics.com/
Revenue $4 million
Funding $94 million
Employees 13 (9 on RocketReach)
Founded 2016
Phone (617) 206-2020
Technologies
Industry Biotechnology Research, Drug Manufacturing & Research, Collaboration, Pharmaceuticals, Genetics, Healthcare, Biotechnology, Health Care, Therapeutics
Competitors Agios Pharmaceuticals, Geron Corporation, Global Blood Therapeutics, Inc., GlycoMimetics, Supernus Pharmaceuticals, Inc.
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies

Imara Inc. Questions

The Imara Inc. annual revenue was $4 million in 2024.

Wendy Kwan is the Director of Finance and Controller of Imara Inc..

9 people are employed at Imara Inc..

Imara Inc. is based in Boston, Massachusetts.

The NAICS codes for Imara Inc. are [32541, 3254, 325, 32].

The SIC codes for Imara Inc. are [28, 283].

Top Imara Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users